AST5902
AST5902 is the active metabolite of Furmonertinib (HY-112870) with antitumor activity, and acts as a EGFR inhibitor. AST5902 inhibits CYP3A4 mRNA transcription at low concentrations and induces CYP3A4 mRNA expression at high concentrations. AST5902 can be used in research related to non-small cell lung cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2412155-74-7
- Formule: C27H29F3N8O2
- Masse moléculaire:554.57
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform EGFR
More
Activité biologique
Description
IC50 & Target
|
CYP3A4 |
EGFR |
In Vitro
AST5902 exhibits anti-tumor activity comparable to that of its parent compound Furmonertinib (HY-112870), a potent EGFR inhibitor.[1]
AST5902 is generated via CYP3A4-mediated N-demethylation of Furmonertinib in human liver microsomes[2].
AST5902 (0.003‑5 μM) modulates CYP3A4 mRNA expression in primary human hepatocytes, exhibiting weak to moderate CYP3A4 induction activity with an EC50 ranging from 0.13‑0.68 μM, and inhibits CYP3A4 mRNA transcription at low concentrations[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2412155-74-7
-
Masse moléculaire 554.57
-
Formule C27H29F3N8O2
-
SMILES
C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OCC(F)(F)F)N=C1N(C)CCNC)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)